메뉴 건너뛰기
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics
Volumn , Issue , 2012, Pages 73-84
IGF system and breast cancer
Author keywords

[No Author keywords available]
Indexed keywords

EID: 84877817736     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-0598-6_4     Document Type: Chapter
Times cited : (1)
References (86)
  • 1
    • 77951028448 scopus 로고    scopus 로고
    • Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer
    • Ahn, B. Y., A. N. Elwi, B. Lee, D. L. Trinh, A. C. Klimowicz, A. Yau, J. A. Chan, A. Magliocco, and S. W. Kim. 2010. Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer. Cancer Res 70:3013-9.
    • (2010) Cancer Res , vol.70 , pp. 3013-3019
    • Ahn, B.Y.1    Elwi, A.N.2    Lee, B.3    Trinh, D.L.4    Klimowicz, A.C.5    Yau, A.6    Chan, J.A.7    Magliocco, A.8    Kim, S.W.9
  • 2
    • 4143074965 scopus 로고    scopus 로고
    • An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis
    • Alexia, C., G. Fallot, M. Lasfer, G. Schweizer-Groyer, and A. Groyer. 2004. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 68:1003-15.
    • (2004) Biochem Pharmacol , vol.68 , pp. 1003-1015
    • Alexia, C.1    Fallot, G.2    Lasfer, M.3    Schweizer-groyer, G.4    Groyer, A.5
  • 4
    • 0028032895 scopus 로고
    • Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
    • Araki, E., M. A. Lipes, M. E. Patti, J. C. Bruning, B. Haag, 3rd, R. S. Johnson, and C. R. Kahn. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-90.
    • (1994) Nature , vol.372 , pp. 186-190
    • Araki, E.1    Lipes, M.A.2    Patti, M.E.3    Bruning, J.C.4    Haag, B.5    Johnson, R.S.6    Kahn, C.R.7
  • 5
    • 0024460381 scopus 로고
    • Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice
    • Arteaga, C. L., L. J. Kitten, E. B. Coronado, S. Jacobs, F. C. Kull, Jr., D. C. Allred, and C. K. Osborne. 1989. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418-23.
    • (1989) J Clin Invest , vol.84 , pp. 1418-1423
    • Arteaga, C.L.1    Kitten, L.J.2    Coronado, E.B.3    Jacobs, S.4    Kull, F.C.5    Allred, D.C.6    Osborne, C.K.7
  • 6
    • 0032486339 scopus 로고    scopus 로고
    • Insulinlike growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity
    • Bae, M. H., M. J. Lee, S. K. Bae, O. H. Lee, Y. M. Lee, B. C. Park, and K. W. Kim. 1998. Insulinlike growth factor II (IGF-II) secreted from HepG2 human hepatocellular carcinoma cells shows angiogenic activity. Cancer Lett 128:41-6.
    • (1998) Cancer Lett , vol.128 , pp. 41-46
    • Bae, M.H.1    Lee, M.J.2    Bae, S.K.3    Lee, O.H.4    Lee, Y.M.5    Park, B.C.6    Kim, K.W.7
  • 8
    • 50549123220 scopus 로고
    • On the treatment of inoperable cases of carcinoma of the mamma. Suggestions for a new method of treatment with illustrative cases
    • Beatson, G. T. 1896. On the treatment of inoperable cases of carcinoma of the mamma. Suggestions for a new method of treatment with illustrative cases. Lancet 2:104-107.
    • (1896) Lancet , vol.2 , pp. 104-107
    • Beatson, G.T.1
  • 9
    • 0034327982 scopus 로고    scopus 로고
    • Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation
    • Bermont, L., S. Fauconnet, F. Lamielle, and G. L. Adessi. 2000. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation. Cell Mol Biol (Noisy-le-grand) 46:1173-82.
    • (2000) Cell Mol Biol (Noisy-le-grand) , vol.46 , pp. 1173-1182
    • Bermont, L.1    Fauconnet, S.2    Lamielle, F.3    Adessi, G.L.4
  • 10
    • 1542725074 scopus 로고    scopus 로고
    • Diet and cancer--the European Prospective Investigation into Cancer and Nutrition
    • Bingham, S., and E. Riboli. 2004. Diet and cancer--the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 4:206-15.
    • (2004) Nat Rev Cancer , vol.4 , pp. 206-215
    • Bingham, S.1    Riboli, E.2
  • 11
    • 0031840476 scopus 로고    scopus 로고
    • Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
    • Bohlke, K., D. W. Cramer, D. Trichopoulos, and C. S. Mantzoros. 1998. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9:570-3.
    • (1998) Epidemiology , vol.9 , pp. 570-573
    • Bohlke, K.1    Cramer, D.W.2    Trichopoulos, D.3    Mantzoros, C.S.4
  • 12
    • 0034748607 scopus 로고    scopus 로고
    • Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds
    • Bonnette, S. G., and D. L. Hadsell. 2001. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142:4937-45.
    • (2001) Endocrinology , vol.142 , pp. 4937-4945
    • Bonnette, S.G.1    Hadsell, D.L.2
  • 13
    • 0029129747 scopus 로고
    • Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer
    • Bruning, P. F., J. Van Doorn, J. M. Bonfrer, P. A. Van Noord, C. M. Korse, T. C. Linders, and A. A. Hart. 1995. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62:266-70.
    • (1995) Int J Cancer , vol.62 , pp. 266-270
    • Bruning, P.F.1    Van Doorn, J.2    Bonfrer, J.M.3    Van Noord, P.A.4    Korse, C.M.5    Linders, T.C.6    Hart, A.A.7
  • 14
    • 0036963448 scopus 로고    scopus 로고
    • Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells
    • Camirand, A., Y. Lu, and M. Pollak. 2002. Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells. Med Sci Monit 8:BR521-6.
    • (2002) Med Sci Monit , vol.8 , pp. BR521-BR526
    • Camirand, A.1    Lu, Y.2    Pollak, M.3
  • 16
    • 34848845313 scopus 로고    scopus 로고
    • Modifying IGF1 activity: An approach to treat endocrine disorders, atherosclerosis and cancer
    • Clemmons, D. R. 2007. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 6:821-33.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 821-833
    • Clemmons, D.R.1
  • 17
    • 51649091930 scopus 로고    scopus 로고
    • Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
    • Creighton, C. J., A. Casa, Z. Lazard, S. Huang, A. Tsimelzon, S. G. Hilsenbeck, C. K. Osborne, and A. V. Lee. 2008. Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol 26:4078-85.
    • (2008) J Clin Oncol , vol.26 , pp. 4078-4085
    • Creighton, C.J.1    Casa, A.2    Lazard, Z.3    Huang, S.4    Tsimelzon, A.5    Hilsenbeck, S.G.6    Osborne, C.K.7    Lee, A.V.8
  • 18
    • 33947286775 scopus 로고    scopus 로고
    • Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells
    • Dalmizrak, O., A. Wu, J. Chen, H. Sun, F. E. Utama, D. Zambelli, T. H. Tran, H. Rui, and R. Baserga. 2007. Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. Cancer Res 67:2124-30.
    • (2007) Cancer Res , vol.67 , pp. 2124-2130
    • Dalmizrak, O.1    Wu, A.2    Chen, J.3    Sun, H.4    Utama, F.E.5    Zambelli, D.6    Tran, T.H.7    Rui, H.8    Baserga, R.9
  • 19
    • 0035114948 scopus 로고    scopus 로고
    • Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells
    • Damon, S. E., S. R. Plymate, J. M. Carroll, C. C. Sprenger, C. Dechsukhum, J. L. Ware, and C. T. Roberts, Jr. 2001. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells. Endocrinology 142:21-7.
    • (2001) Endocrinology , vol.142 , pp. 21-27
    • Damon, S.E.1    Plymate, S.R.2    Carroll, J.M.3    Sprenger, C.C.4    Dechsukhum, C.5    Ware, J.L.6    Roberts, C.T.7
  • 20
    • 56749096810 scopus 로고    scopus 로고
    • Elevated free IGF2 levels in localized, early-stage breast cancer in women
    • Espelund, U., S. Cold, J. Frystyk, H. Orskov, and A. Flyvbjerg. 2008. Elevated free IGF2 levels in localized, early-stage breast cancer in women. Eur J Endocrinol 159:595-601.
    • (2008) Eur J Endocrinol , vol.159 , pp. 595-601
    • Espelund, U.1    Cold, S.2    Frystyk, J.3    Orskov, H.4    Flyvbjerg, A.5
  • 21
    • 57149137029 scopus 로고    scopus 로고
    • Crosstalk between IGF1R and estrogen receptor signaling in breast cancer
    • Fagan, D. H., and D. Yee. 2008. Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13:423-9.
    • (2008) J Mammary Gland Biol Neoplasia , vol.13 , pp. 423-429
    • Fagan, D.H.1    Yee, D.2
  • 22
    • 0028293446 scopus 로고
    • Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines
    • Favoni, R. E., A. de Cupis, F. Ravera, C. Cantoni, P. Pirani, A. Ardizzoni, D. Noonan, and R. Biassoni. 1994. Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines. Int J Cancer 56:858-66.
    • (1994) Int J Cancer , vol.56 , pp. 858-866
    • Favoni, R.E.1    de Cupis, A.2    Ravera, F.3    Cantoni, C.4    Pirani, P.5    Ardizzoni, A.6    Noonan, D.7    Biassoni, R.8
  • 24
    • 0021364464 scopus 로고
    • Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture
    • Furlanetto, R. W., and J. N. DiCarlo. 1984. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res 44:2122-8.
    • (1984) Cancer Res , vol.44 , pp. 2122-2128
    • Furlanetto, R.W.1    DiCarlo, J.N.2
  • 25
    • 10344247119 scopus 로고    scopus 로고
    • A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts
    • Goetsch, L., A. Gonzalez, O. Leger, A. Beck, P. J. Pauwels, J. F. Haeuw, and N. Corvaia. 2005. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts. Int J Cancer 113:316-28.
    • (2005) Int J Cancer , vol.113 , pp. 316-328
    • Goetsch, L.1    Gonzalez, A.2    Leger, O.3    Beck, A.4    Pauwels, P.J.5    Haeuw, J.F.6    Corvaia, N.7
  • 27
    • 42049096107 scopus 로고    scopus 로고
    • Paclitaxel plus bevacizumab for metastatic breast cancer
    • author reply 1637-8
    • Haines, I. E., and G. L. Miklos. 2008. Paclitaxel plus bevacizumab for metastatic breast cancer. N Engl J Med 358:1637; author reply 1637-8.
    • (2008) N Engl J Med , vol.358 , pp. 1637
    • Haines, I.E.1    Miklos, G.L.2
  • 29
    • 0036018897 scopus 로고    scopus 로고
    • The insulin-like growth factor system as a therapeutic target in colorectal cancer
    • Hassan, A. B., and V. M. Macaulay. 2002. The insulin-like growth factor system as a therapeutic target in colorectal cancer. Ann Oncol 13:349-56.
    • (2002) Ann Oncol , vol.13 , pp. 349-356
    • Hassan, A.B.1    Macaulay, V.M.2
  • 30
    • 33750139113 scopus 로고    scopus 로고
    • Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer
    • Hopfner, M., A. P. Sutter, A. Huether, V. Baradari, and H. Scherubl. 2006. Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer. World J Gastroenterol 12:5635-43.
    • (2006) World J Gastroenterol , vol.12 , pp. 5635-5643
    • Hopfner, M.1    Sutter, A.P.2    Huether, A.3    Baradari, V.4    Scherubl, H.5
  • 33
    • 33746867442 scopus 로고    scopus 로고
    • Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo
    • Jerome, L., N. Alami, S. Belanger, V. Page, Q. Yu, J. Paterson, L. Shiry, M. Pegram, and B. Leyland-Jones. 2006. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo. Cancer Res 66:7245-52.
    • (2006) Cancer Res , vol.66 , pp. 7245-7252
    • Jerome, L.1    Alami, N.2    Belanger, S.3    Page, V.4    Yu, Q.5    Paterson, J.6    Shiry, L.7    Pegram, M.8    Leyland-jones, B.9
  • 34
    • 0347087571 scopus 로고    scopus 로고
    • Deregulation of the IGF axis in cancer: Epidemiological evidence and potential therapeutic interventions
    • Jerome, L., L. Shiry, and B. Leyland-Jones. 2003. Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions. Endocr Relat Cancer 10:561-78.
    • (2003) Endocr Relat Cancer , vol.10 , pp. 561-578
    • Jerome, L.1    Shiry, L.2    Leyland-jones, B.3
  • 35
    • 0027515722 scopus 로고
    • Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence
    • Jones, J. I., A. Gockerman, W. H. Busby, Jr., G. Wright, and D. R. Clemmons. 1993. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90:10553-7.
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 10553-10557
    • Jones, J.I.1    Gockerman, A.2    Busby, W.H.3    Wright, G.4    Clemmons, D.R.5
  • 36
    • 0030876829 scopus 로고    scopus 로고
    • Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency
    • Juul, A., K. Holm, K. W. Kastrup, S. A. Pedersen, K. F. Michaelsen, T. Scheike, S. Rasmussen, J. Muller, and N. E. Skakkebaek. 1997. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82:2497-502.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 2497-2502
    • Juul, A.1    Holm, K.2    Kastrup, K.W.3    Pedersen, S.A.4    Michaelsen, K.F.5    Scheike, T.6    Rasmussen, S.7    Muller, J.8    Skakkebaek, N.E.9
  • 37
    • 77949657070 scopus 로고    scopus 로고
    • Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity
    • Kalla Singh, S., Q. W. Tan, C. Brito, M. De Leon, C. Garberoglio, and D. De Leon. 2010. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity. Growth Horm IGF Res 20:162-70.
    • (2010) Growth Horm IGF Res , vol.20 , pp. 162-170
    • Kalla Singh, S.1    Tan, Q.W.2    Brito, C.3    De Leon, M.4    Garberoglio, C.5    De Leon, D.6
  • 38
    • 28244468422 scopus 로고    scopus 로고
    • Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer
    • Kostler, W. J., G. Hudelist, W. Rabitsch, K. Czerwenka, R. Muller, C. F. Singer, and C. C. Zielinski. 2006. Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer. J Cancer Res Clin Oncol 132:9-18.
    • (2006) J Cancer Res Clin Oncol , vol.132 , pp. 9-18
    • Kostler, W.J.1    Hudelist, G.2    Rabitsch, W.3    Czerwenka, K.4    Muller, R.5    Singer, C.F.6    Zielinski, C.C.7
  • 40
    • 0031587697 scopus 로고    scopus 로고
    • Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors
    • LeRoith, D. 1997. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 336:633-40.
    • (1997) N Engl J Med , vol.336 , pp. 633-640
    • LeRoith, D.1
  • 41
    • 0031964011 scopus 로고    scopus 로고
    • IGF system components as prognostic markers in breast cancer
    • Lee, A. V., S. G. Hilsenbeck, and D. Yee. 1998. IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat 47:295-302.
    • (1998) Breast Cancer Res Treat , vol.47 , pp. 295-302
    • Lee, A.V.1    Hilsenbeck, S.G.2    Yee, D.3
  • 42
    • 0027746287 scopus 로고
    • Insulin-like growth factors and their receptors in normal physiology and pathological states
    • LeRoith, D., and C. T. Roberts, Jr. 1993. Insulin-like growth factors and their receptors in normal physiology and pathological states. J Pediatr Endocrinol 6:251-5.
    • (1993) J Pediatr Endocrinol , vol.6 , pp. 251-255
    • LeRoith, D.1    Roberts, C.T.2
  • 44
    • 71549146268 scopus 로고    scopus 로고
    • Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion
    • Mardilovich, K., and L. M. Shaw. 2009. Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion. Cancer Res 69:8894-901.
    • (2009) Cancer Res , vol.69 , pp. 8894-8901
    • Mardilovich, K.1    Shaw, L.M.2
  • 45
    • 0026799489 scopus 로고
    • Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: Use of IGFBP-1 as an inhibitor of insulin-like growth factor action
    • McGuire, W. L., Jr., J. G. Jackson, J. A. Figueroa, S. Shimasaki, D. R. Powell, and D. Yee. 1992. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 84:1336-41.
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1336-1341
    • McGuire, W.L.1    Jackson, J.G.2    Figueroa, J.A.3    Shimasaki, S.4    Powell, D.R.5    Yee, D.6
  • 46
    • 0034885755 scopus 로고    scopus 로고
    • Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK
    • McKinnon, T., C. Chakraborty, L. M. Gleeson, P. Chidiac, and P. K. Lala. 2001. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 86:3665-74.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 3665-3674
    • McKinnon, T.1    Chakraborty, C.2    Gleeson, L.M.3    Chidiac, P.4    Lala, P.K.5
  • 49
    • 0036803018 scopus 로고    scopus 로고
    • IGF-binding proteins are multifunctional and act via IGF- dependent and -independent mechanisms
    • Mohan, S., and D. J. Baylink. 2002. IGF-binding proteins are multifunctional and act via IGF- dependent and -independent mechanisms. J Endocrinol 175:19-31.
    • (2002) J Endocrinol , vol.175 , pp. 19-31
    • Mohan, S.1    Baylink, D.J.2
  • 52
    • 0024369203 scopus 로고
    • Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor
    • Osborne, C. K., E. B. Coronado, L. J. Kitten, C. I. Arteaga, S. A. Fuqua, K. Ramasharma, M. Marshall, and C. H. Li. 1989. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3:1701-9.
    • (1989) Mol Endocrinol , vol.3 , pp. 1701-1709
    • Osborne, C.K.1    Coronado, E.B.2    Kitten, L.J.3    Arteaga, C.I.4    Fuqua, S.A.5    Ramasharma, K.6    Marshall, M.7    Li, C.H.8
  • 53
    • 61649096363 scopus 로고    scopus 로고
    • Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes
    • Palsgaard, J., A. E. Brown, M. Jensen, R. Borup, M. Walker, and P. De Meyts. 2009. Insulin-like growth factor I (IGF-I) is a more potent regulator of gene expression than insulin in primary human myoblasts and myotubes. Growth Horm IGF Res 19:168-78.
    • (2009) Growth Horm IGF Res , vol.19 , pp. 168-178
    • Palsgaard, J.1    Brown, A.E.2    Jensen, M.3    Borup, R.4    Walker, M.5    De Meyts, P.6
  • 55
    • 57149142363 scopus 로고    scopus 로고
    • IGF binding proteins (IGFBPs) and regulation of breast cancer biology
    • Perks, C. M., and J. M. Holly. 2008. IGF binding proteins (IGFBPs) and regulation of breast cancer biology. J Mammary Gland Biol Neoplasia 13:455-69.
    • (2008) J Mammary Gland Biol Neoplasia , vol.13 , pp. 455-469
    • Perks, C.M.1    Holly, J.M.2
  • 56
    • 0032952577 scopus 로고    scopus 로고
    • Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells
    • Perks, C. M., P. V. Newcomb, M. R. Norman, and J. M. Holly. 1999. Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. J Mol Endocrinol 22:141-50.
    • (1999) J Mol Endocrinol , vol.22 , pp. 141-150
    • Perks, C.M.1    Newcomb, P.V.2    Norman, M.R.3    Holly, J.M.4
  • 59
    • 0023473304 scopus 로고
    • Presence of somatomedin receptors on primary human breast and colon carcinomas
    • Pollak, M. N., J. F. Perdue, R. G. Margolese, K. Baer, and M. Richard. 1987. Presence of somatomedin receptors on primary human breast and colon carcinomas. Cancer Lett 38:223-30.
    • (1987) Cancer Lett , vol.38 , pp. 223-230
    • Pollak, M.N.1    Perdue, J.F.2    Margolese, R.G.3    Baer, K.4    Richard, M.5
  • 61
    • 20344397362 scopus 로고    scopus 로고
    • IGF-I, IGF binding protein-3 and breast cancer risk: Comparison of 3 meta-analyses
    • author reply 1008
    • Renehan, A. G., M. Egger, C. Minder, S. T. O'Dwyer, S. M. Shalet, and M. Zwahlen. 2005. IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 115:1006-7; author reply 1008.
    • (2005) Int J Cancer , vol.115 , pp. 1006-1007
    • Renehan, A.G.1    Egger, M.2    Minder, C.3    O'Dwyer, S.T.4    Shalet, S.M.5    Zwahlen, M.6
  • 62
    • 1942436958 scopus 로고    scopus 로고
    • Insulinlike growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and metaregression analysis
    • Renehan, A. G., M. Zwahlen, C. Minder, S. T. O'Dwyer, S. M. Shalet, and M. Egger. 2004. Insulinlike growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and metaregression analysis. Lancet 363:1346-53.
    • (2004) Lancet , vol.363 , pp. 1346-1353
    • Renehan, A.G.1    Zwahlen, M.2    Minder, C.3    O'Dwyer, S.T.4    Shalet, S.M.5    Egger, M.6
  • 65
    • 33846807433 scopus 로고    scopus 로고
    • Disrupting insulin-like growth factor signaling as a potential cancer therapy
    • Sachdev, D., and D. Yee. 2007. Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Cancer Ther 6:1-12.
    • (2007) Mol Cancer Ther , vol.6 , pp. 1-12
    • Sachdev, D.1    Yee, D.2
  • 67
    • 3242884950 scopus 로고    scopus 로고
    • IGF-I and breast cancer: A meta-analysis
    • Shi, R., H. Yu, J. McLarty, and J. Glass. 2004. IGF-I and breast cancer: a meta-analysis. Int J Cancer 111:418-23.
    • (2004) Int J Cancer , vol.111 , pp. 418-423
    • Shi, R.1    Yu, H.2    McLarty, J.3    Glass, J.4
  • 70
    • 0042926509 scopus 로고    scopus 로고
    • Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer
    • Stoeltzing, O., W. Liu, N. Reinmuth, F. Fan, A. A. Parikh, C. D. Bucana, D. B. Evans, G. L. Semenza, and L. M. Ellis. 2003. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am J Pathol 163:1001-11.
    • (2003) Am J Pathol , vol.163 , pp. 1001-1011
    • Stoeltzing, O.1    Liu, W.2    Reinmuth, N.3    Fan, F.4    Parikh, A.A.5    Bucana, C.D.6    Evans, D.B.7    Semenza, G.L.8    Ellis, L.M.9
  • 71
  • 72
    • 3142726250 scopus 로고    scopus 로고
    • Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: A meta-analysis of literature
    • Sugumar, A., Y. C. Liu, Q. Xia, Y. S. Koh, and K. Matsuo. 2004. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature. Int J Cancer 111:293-7.
    • (2004) Int J Cancer , vol.111 , pp. 293-297
    • Sugumar, A.1    Liu, Y.C.2    Xia, Q.3    Koh, Y.S.4    Matsuo, K.5
  • 74
    • 79952118027 scopus 로고    scopus 로고
    • Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density
    • Taverne, C. W., M. Verheus, J. D. McKay, R. Kaaks, F. Canzian, D. E. Grobbee, P. H. Peeters, and C. H. van Gils. 2010. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density. Breast Cancer Res Treat.
    • (2010) Breast Cancer Res Treat
    • Taverne, C.W.1    Verheus, M.2    McKay, J.D.3    Kaaks, R.4    Canzian, F.5    Grobbee, D.E.6    Peeters, P.H.7    van Gils, C.H.8
  • 76
    • 16944364325 scopus 로고    scopus 로고
    • Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation
    • Turner, B. C., B. G. Haffty, L. Narayanan, J. Yuan, P. A. Havre, A. A. Gumbs, L. Kaplan, J. L. Burgaud, D. Carter, R. Baserga, and P. M. Glazer. 1997. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57:3079-83.
    • (1997) Cancer Res , vol.57 , pp. 3079-3083
    • Turner, B.C.1    Haffty, B.G.2    Narayanan, L.3    Yuan, J.4    Havre, P.A.5    Gumbs, A.A.6    Kaplan, L.7    Burgaud, J.L.8    Carter, D.9    Baserga, R.10    Glazer, P.M.11
  • 77
    • 0032702836 scopus 로고    scopus 로고
    • Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women
    • Vadgama, J. V., Y. Wu, G. Datta, H. Khan, and R. Chillar. 1999. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 57:330-40.
    • (1999) Oncology , vol.57 , pp. 330-340
    • Vadgama, J.V.1    Wu, Y.2    Datta, G.3    Khan, H.4    Chillar, R.5
  • 79
    • 0029793594 scopus 로고    scopus 로고
    • The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis
    • Volpert, O., D. Jackson, N. Bouck, and D. I. Linzer. 1996. The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 137:3871-6.
    • (1996) Endocrinology , vol.137 , pp. 3871-3876
    • Volpert, O.1    Jackson, D.2    Bouck, N.3    Linzer, D.I.4
  • 80
    • 0031616132 scopus 로고    scopus 로고
    • The IRS-signaling system: A network of docking proteins that mediate insulin and cytokine action
    • White, M. F. 1998. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res 53:119-38.
    • (1998) Recent Prog Horm Res , vol.53 , pp. 119-138
    • White, M.F.1
  • 81
    • 0028040380 scopus 로고
    • Regulation of insulin-like growth factors by antiestrogen
    • Winston, R., P. C. Kao, and D. T. Kiang. 1994. Regulation of insulin-like growth factors by antiestrogen. Breast Cancer Res Treat 31:107-15.
    • (1994) Breast Cancer Res Treat , vol.31 , pp. 107-115
    • Winston, R.1    Kao, P.C.2    Kiang, D.T.3
  • 83
    • 0033842834 scopus 로고    scopus 로고
    • Crosstalk between the insulin-like growth factors and estrogens in breast cancer
    • Yee, D., and A. V. Lee. 2000. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 5:107-15.
    • (2000) J Mammary Gland Biol Neoplasia , vol.5 , pp. 107-115
    • Yee, D.1    Lee, A.V.2
  • 85
    • 0036682286 scopus 로고    scopus 로고
    • Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility
    • Zhang, X., and D. Yee. 2002. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Res 62:4369-75.
    • (2002) Cancer Res , vol.62 , pp. 4369-4375
    • Zhang, X.1    Yee, D.2
  • 86
    • 0346500576 scopus 로고    scopus 로고
    • Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism
    • Zofkova, I. 2003. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiol Res 52:657-79.
    • (2003) Physiol Res , vol.52 , pp. 657-679
    • Zofkova, I.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.